We have diverse interests in Cancer/Radiation Biology and Inflamatory Diseases. Here are only some of the in-depth projects currently undergoing in the lab. Since we're trying to pursue 'TRANSLATION RESEARCH' (i.e., clinical implication & applicability), please take a look at 'Collaborators' section below for more information on our latest research interests.
GO GET EM TIGER!
Macrophages are well known for their protumoral roles. Recently we have reported that macrophages can exacerbate tumor hypoxia and aerobic glycolysis. If they can consume oxygen and glucose, how will they regulate T cell functions and immunotherapy? How can we block macrophages? What signaling in macrophages is responsible for this phenomenon? We have all the know-hows and the newest mouse lung cancer model (ALK overexpression) mimicking patients in the lab to address this question!
FLASH, THE NEW RADIOTHERAPY ON THE BLOCK!
In the clinic, we treat tumors with radiotherapy using LINAC (linear accelerator), proton radiotherapy, or carbon (particle) radiotherapy. In collaboration with Stanford University, US, we are exploring novel biological mechanisms (effects in the tumor microenvironment) from the latest radiotherapy technique called FLASH. This is ultra-fast dose rate ionizing radiotherapy, which can deliver 20 Gy (very high dose of ionizing radiation) in just a couple of seconds!
YOUR FAT , YOUR GENE IN MACROPHAGES!
We have recently created novel myeloid-specific knockout mice in hypoxia-inducible factor (HIF) signaling pathway and found that these mice exhibit anti-obese phenotype. We're currently investigating the molecular mechanisms and seeing that it is Hif-alpha gene in macrophages regulating the diet-induced obesity. We're expanding this idea to Cancer Biology to see how macrophage could regulate fat metabolism in cancer cells.
BETTER MOUSE MODEL FOR BETTER IMMUNOTHERAPY TO TREAT LUNG CANCER!
Current response rate for the latest immunotherapy (PD-1 or PD-L1 bloackdes) in lung cancer patients (NSCLC) is only about 30%. To increase the effectiveness of immunotherapy, we need to understand how immune cells function and interact with each other during the lung cancer progression. We have a novel strain of mouse lung cancer mimicking NSCLC patients (ALK overexpressed tumors) to address this.
SEEING IS BELIEVING!
We are interested in the real-time in vivo imaging of macrophages (and other immune cells such as T cells) infiltrating into tumors using the dorsal (and intracranial) window chamber techniques that we have established in our lab. We can powerfully manipulate cancer cells so that they can express reporters upon metabolic/stress conditions. In addition, we can study the mechanisms of various anticancer modalities (such as DNA repair inhibitors, checkpoint blockades, and anti-angiogenic agents) in live mice.
ARE YOU BREATHING?
OXYGEN-SENSING IN MACROPHAGES!
We have recently reported that tumor-associated macrophages (TAM) can compete with cancer cells for oxygen and glucose. Does hypoxia-inducible factor (HIF) regulate this mechanism? Does this occur in other metabolic diseases such as obsity and cancer cachexia? We have novel strains of mice targeting HIF pathways in macrophages to address this!
Major publications only
Feb 15, 2019
TUMOR-ASSOCIATED MACROPHAGES ENAHNCE TUMOR HYPOXIA AND AEROBIC GLYCOLYSIS
Jeong & Kim et al., Cancer Res (2019), 79(4):795-806
Hoibin Jeong received 2016 POSCO CheongAm Graduate Fellowship, 2019 Best Research Paper in the Dept Life Science POSTECH
Chan-Ju Lee received 2015 Young Investigator Award (ICRR, Kyoto, Japan)
Introduced at BioWorld, Editor's Choice
Jul 30, 2018
HIF-1A ACTIVATION IN MYELOID CELLS ACCELERATES DEXTRAN SODIUM SULFATE-INDUCED COLITIS PROGRESSION IN MICE
Kim et al., Dis Model Mech (2018) 11(7), pii:dmm033241
Young-Eun Kim received 2012 Global PhD Fellowship, 2015 Keystone Scholarship (Dublin, Ireland), 2018 KSMCB Best Poster Award (Seoul, Korea)
Jeongwoo Kim received 2016 Global PhD Fellowship
Sujin Yeo received 2014 Global PhD Fellowship
Dec 1, 2017
HYPOXIA-INDUCIBLE FACTOR-1A REGULATES MICROGLIAL FUNCTIONS AFFECTING NEURONAL SURVIVAL IN THE ACUTE PHASE OF ISCHEMIC STROKE IN MICE
Oncotarget (2017), 8(67), 111508-111521
Seoyeon Bok is currently doing her postdoctoral fellowship in Cornell University, US
TUMOR HYPOXIA AND REOXYGENATION: THE YIN AND YANG FOR RADIOTHERAPY
Hong et al., Radiat Oncol J (2016), 34(4), 239-249
Beom-Ju Hong received 2013 Global PhD Fellowship, 2015 Junior Investigator Award (ICRR, Kyoto, Japan), 2015 Excellent Poster Award (ICRR, Kyoto, Japan), 2017 Junior Investigator Award (Tumor Microenvironment Workshop, Florida, US)
Jul 1, 2016
RADIATION-INDUCED ESOPHAGITIS IN VIVO AND IN VITRO REVEALS THAT EPIDERMAL GROWTH FACTOR IS A POTENTIAL CANDIDATE FOR THERAPEUTIC INTERVENTION STRATEGY.
Kim & Jeon et al., Int J Radiat Oncol Biol Phys (2016), 95(3), 1032-1041
Jul 1, 2016
REAL-TIME TUMOR OXYGENATION CHANGES AFTER SINGLE HIGH-DISE RADIATION THERAPY IN ORTHOTOPIC AND SUBCUTANOUES LUNG CANCER IN MICE: CLINICAL IMPLICATION FOR STEREOTACTIC ABLATIVE RADIATION THERAPY SCHEDULE OPTIMIZATION.
Song & Hong et al., Int J Radiat Oncol Biol Phys (2016), 95(3), 1022-1031
Introduced as research highlight
Commented by Editor-in-Chief at PodCast
May 4, 2010
INHIBITION OF MAC-1 (CD11B/CD18) ENHANCES TUMOR RESPONSE TO RADIATION BY REDUCING MYELOID CELL RECRUITMENT
Ahn et al., PNAS (2010), 107(18), 8363-8368
Introduced as research highlight at Nature Medicine
MATRIX METALLOPROTEINASE-9 IS REQUIRED FOR TUMOR VASCULOGENESIS BUT NOT FOR ANGIOGENESIS: ROLE OF BONE MARROW-DERIVED MYELOMONOCYTIC CELLS
Ahn & Brown, Cancer Cell (2008), 13(3), 193-205
Introduced as research highlight
Jun 14, 2006
RADIOLYTIC AND CELLULAR REDUCTION OF A NOVEL HYPOXIA-ACTIVATED COBALT (III) PRODRUG OF A CHLOROMETHYLBENZINDOLINE DNA MINOR GROOVE ALKYLATOR
Ahn et al., Biochem Pharmacol (2006), 71(12), 1683-1694
OPTIMIZATION OF THE AUXILIARY LIGAND SHELL OF COBALT(III)(8-HYDROXYQUINOLINE) COMPLEXES AS MODEL HYPOXIA-SELECTIVE RADIATION-ACTIVATED PRODRUGS
Ahn et al., Radiat Res (2004), 162(3), 315-325
Current lab members
G-ONE AHN, PH.D.
PI (Lab Head)
2019.09~present: Associate Professor, Seoul National University College of Veterinary Medicine
2020.03~present: Adjunct Professor, Seoul National University College of Medicine (Cancer Biology Collaborative Course)
2017.03~2017.09: Visiting Professor, Stem Cell Institute and Regenerative Medicine, Stanford University School of Medicine (Irving L. Weissman's lab)
2015.09~2019.08: Associate Professor, Integrative Biosciences Biotechnology(IBB)/Life Science, POSTECH (Pohang University of Science and Technology)
2011.04~2015.08: Assistant Professor, IBB, POSTECH
2008.09~2011.03: Research Associate, Stanford University School of Medicine (Dept Radiation Oncology, J. Martin Brown's lab)
2003.09~2008.08: Postdoc, Stanford University School of Medicine (Dept Radiation Oncology, J. Martin Brown's lab)
2000.03~2003.08: Ph.D. in Pathology, The University of Auckland, Auckland, New Zealand (Auckland Cancer Society Research Centre, William R. Wilson's lab)
1998.03~2000.02: M.Sc. (Hons) in Pharmacology, The University of Auckland, Auckland, New Zealand (Mark J. McKeage's lab)
1995.03~1998.02: B.Sc. in Chemistry & Pharmacology, The University of Auckland, Auckland, New Zealand
MYEONG SU KIM, B.S.
Graduate Student (MS-PhD Combined)
2020.03~present: Graduate student, College of Veterinary Medicine, Seoul National University
2019.12~2020.02: Researcher, College of Veterinary Medicine, Seoul National University
2019.08~2019.09: Internship, College of Medicine, Seoul National University
2018.07~2018.08: Internship, Yonsei University College of Medicine
2019.02: BS, Biology & Chemistry Major, Konkuk University
2018.09: Publishing e-book 'Hello, First time in the lab?'
DAWIT OH, B.S.
2020.07~present: Researcher, College of Veterinary Medicine, Seoul National University
2019.07~2019.07: Internship, Kunkuk University
2018.07~2018.08: Internship, Korea University College of Medicine
2017.07~2017.09: Internship, Sapporo Gakuin University
2020.09: BS, Biomedical Engineering Major, Konkuk University
SEO HEE RYU
2020.07~present: Internship student, College of Veterinary Medicine, Seoul National University
2017.09~present: Undergraduate student, UC Davis, CA, USA
Past lab members
(students & postdocs only)
Graduate students, postdocs, and more!
Open for 2021 Spring Semester Admission
We are actively recruiting graduate students for MS-PhD combined or PhD degrees. If interested, please e-mail us with your transcript and CV.
Open at all times
We are also actively recruiting postdoctoral research fellows. Those whom have biomedical expertise (Cancer Biology, Immunology, Cell Biology, Molecular Biology, Radiation Biology, Medicine, Veterinary Medicine) are particularly welcome (but not necessary). All fields of expertise are encouraged. If interested, please email your CV with a list of publications.
We hire full-time research technicians. Experience in Cell Biology, Molecular Biology, in vivo mouse handling are particularly preferred but not necessary.
We welcome undergraduate students for internship in the lab. They will experience various aspects of research - performing, writing, reading, and designing research by participating various activities in the lab.
If you're interested, you should write to PI to inquire the application process.
NEWS AND EVENTS
BRUNCH JOURNAL CLUB
Monthly brunch journal club (every 3rd week)
Next BC: Aug 19, 2020
Presenter: G-One Ahn
LAB SOCIAL / DINING OUT!
Once a month get together to dine out
12.18.19 - Lunch @ La Cucina, SNU
01.16.20 - Dinner @ BBQ, NakSungDae
03.17.20 - Lunch @ SoDamMaRu, SNU
04.29.20 - Lunch @ Syaban, SNU
07.03.20 - Dinner @ BBQ Cafe, SNU
07.24.20 - Dinner @ Jeju Black pork BBQ, NakSungDae
LAB NEWS AND VIEWS
Aug 2nd, 2020
We moved from building 85 to building 81!
Checkout the latest mailing address:
Lab: Rm 421
Office: Rm 415
서울시 관악구 관악로 1, 서울대학교 수의과대학 81동 415호
Rm 415, Building 81
College of Veterinary Medicine
Seoul National University
1 Gwanak-ro, Gwanak-gu
Seoul 08826, Korea